Nuvalent (NUVL) Shares Outstanding (Weighted Average) (2020 - 2026)

Nuvalent (NUVL) reported Shares Outstanding (Weighted Average) of $78.7 million for Q1 2026, up 9.86% on a YoY basis from $71.6 million in Q1 2025, and up 8.23% quarter-over-quarter from $72.7 million in Q4 2025.

Nuvalent (NUVL) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

Nuvalent has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $78.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 9.86% year-over-year to $78.7 million; the trailing twelve-month figure through Mar 2026 stood at $78.7 million (up 9.86% YoY), and the FY2025 full-year result was $72.7 million, up 9.45% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $78.7 million, up from $72.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $78.7 million in Q1 2026, with the low at $48.3 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $61.8 million across 5 years, with a median of $64.2 million in 2024.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) jumped 1465.14% — and 2025, when it increased 9.45%.
  • Nuvalent's Shares Outstanding (Weighted Average) stood at $49.7 million in 2022, then gained by 17.22% to $58.2 million in 2023, then gained by 14.06% to $66.4 million in 2024, then advanced by 9.45% to $72.7 million in 2025, then gained by 8.23% to $78.7 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $78.7 million (Q1 2026), $72.7 million (Q4 2025), and $72.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 185,491.37 Bn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 4,489.46 Bn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 118.76 Bn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 417.01 Bn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.71 Bn 91.71 Bn - 928.40 Mn
10 Nuvalent 9.70 Bn 9.70 Bn - 78.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 78.67 Mn
Dec 31, 2025 72.69 Mn
Sep 30, 2025 72.14 Mn
Jun 30, 2025 71.73 Mn
Mar 31, 2025 71.61 Mn
Dec 31, 2024 66.41 Mn
Sep 30, 2024 64.81 Mn
Jun 30, 2024 64.38 Mn
Mar 31, 2024 64.15 Mn
Dec 31, 2023 58.22 Mn
Sep 30, 2023 57.09 Mn
Jun 30, 2023 56.79 Mn
Mar 31, 2023 56.70 Mn
Dec 31, 2022 49.67 Mn
Sep 30, 2022 48.41 Mn
Jun 30, 2022 48.32 Mn
Mar 31, 2022 48.28 Mn
Dec 31, 2021 21.78 Mn
Sep 30, 2021 32.07 Mn
Jun 30, 2021 3.10 Mn